Majumdar A, Tsochatzis E

Idioma: Ingles.
Referencias bibliográficas: 6
Paginas: 440-441
Archivo PDF: 73.76 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK. Vitamin D level and sustained virologic response to interferon- based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. J Hepatol 2014; 61: 1247-52.

2. García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a metaanalysis. Hepatology 2014; 60: 1541-50.

3. Roulot D1, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, Le Clesiau H, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community- based population aged over 45 years. Gut 2011; 60: 977-84.

4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50.

5. Musso G1, Gambino R, Cassader M, Pagano G. Metaanalysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-49.

6. Armstrong MJ1, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59: 1174-97.